RIPK2 inhibitors for disease therapy: Current status and perspectives
Erkang Tian, Changhan Zhou, Shuqi Quan, Chongying Su, Guanning Zhang, Quanwei Yu, Juan Li, Jifa Zhang, Jifa Zhang
Topics & Concepts
Signal transducing adaptor proteinReceptorCell biologySignal transductionDeath domainToll-like receptorCancer researchChemistryInnate immune systemBiologyImmunologyApoptosisBiochemistryProgrammed cell deathinterferon and immune responsesCytokine Signaling Pathways and InteractionsImmune Response and Inflammation